Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DA002543-23
Application #
2116605
Study Section
Special Emphasis Panel (NSS)
Project Start
1980-04-01
Project End
1999-03-31
Budget Start
1996-04-01
Budget End
1997-03-31
Support Year
23
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of South Carolina at Columbia
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
111310249
City
Columbia
State
SC
Country
United States
Zip Code
29208
Alici, Tevfik; Appel, James B (2004) Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide. Pharmacol Biochem Behav 79:431-7
Appel, James B; West, William B; Buggy, James (2004) LSD, 5-HT (serotonin), and the evolution of a behavioral assay. Neurosci Biobehav Rev 27:693-701
West, W B; Lou, A; Pechersky, K et al. (2000) Antagonism of a PCP drug discrimination by hallucinogens and related drugs. Neuropsychopharmacology 22:618-25
Appel, J B; West, W B; Rolandi, W G et al. (1999) Increasing the selectivity of drug discrimination procedures. Pharmacol Biochem Behav 64:353-8
Simon, B; Appel, J B (1997) Dopaminergic and serotonergic properties of fluoxetine. Prog Neuropsychopharmacol Biol Psychiatry 21:169-81
West, W B; Van Groll, B J; Appel, J B (1995) Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms. Pharmacol Biochem Behav 51:69-76
Callahan, P M; Appel, J B; Cunningham, K A (1991) Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology (Berl) 103:50-5
Cunningham, K A; Callahan, P M; Appel, J B (1987) Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics. Eur J Pharmacol 138:29-36